Published in J Clin Microbiol on December 01, 1994
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol (1997) 1.83
Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother (2009) 1.60
An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types. Med Microbiol Immunol (2003) 1.33
Host DNA can interfere with detection of Borrelia burgdorferi in skin biopsy specimens by PCR. J Clin Microbiol (1996) 1.27
Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single-run, real-time PCR. J Clin Microbiol (2002) 1.24
PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev (1997) 1.23
An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis. J Clin Microbiol (1997) 1.15
Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy. J Clin Microbiol (1996) 1.14
Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol (1998) 1.05
A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis. Mol Pathol (1997) 1.00
Borrelia burgdorferi infection and cutaneous Lyme disease, Mexico. Emerg Infect Dis (2007) 0.98
Diagnosis of viral myocarditis by cardiac magnetic resonance and viral genome detection in peripheral blood. Int J Cardiovasc Imaging (2012) 0.94
Sensitive detection of Borrelia burgdorferi sensu lato DNA and differentiation of Borrelia species by LightCycler PCR. J Clin Microbiol (2001) 0.92
Borrelia species in host-seeking ticks and small mammals in northern Florida. J Clin Microbiol (2004) 0.90
Lyme carditis--diagnosis, treatment and prognosis. Dtsch Arztebl Int (2015) 0.81
Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains? Bosn J Basic Med Sci (2015) 0.76
Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society. Ger Med Sci (2017) 0.75
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 95.08
Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36
Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med (1985) 20.49
Lyme disease. N Engl J Med (1989) 14.06
Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol Microbiol (1989) 6.51
Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am J Pathol (1991) 4.59
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med (1994) 4.07
Antibody response in Lyme disease: evaluation of diagnostic tests. J Infect Dis (1984) 4.07
Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis (1993) 3.92
A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction. J Infect Dis (1989) 3.53
A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science (1985) 3.42
Antibiotic therapy in Lyme disease. Ann Intern Med (1980) 2.93
Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi. J Clin Microbiol (1991) 2.71
Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol (1992) 2.69
Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different geographic origins. Infect Immun (1992) 2.67
Detection of Borrelia burgdorferi DNA in museum specimens of Ixodes dammini ticks. Science (1990) 2.58
Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am J Trop Med Hyg (1992) 2.57
Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection. J Immunol (1992) 2.49
Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever. J Clin Microbiol (1992) 2.46
Linear- and circular-plasmid copy numbers in Borrelia burgdorferi. J Bacteriol (1992) 2.45
Detection of Borrelia burgdorferi in patients with Lyme disease by the polymerase chain reaction. J Clin Pathol (1991) 2.23
Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol (1992) 2.12
Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes. Infect Immun (1992) 2.10
The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene. Infect Immun (1990) 2.10
Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann N Y Acad Sci (1988) 1.95
Successful cultivation of spirochetes from skin lesions of patients with erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Acta Pathol Microbiol Immunol Scand B (1985) 1.89
Detection of Borrelia burgdorferi using the polymerase chain reaction. J Clin Microbiol (1990) 1.82
PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology (1992) 1.69
Sequence variation in the outer-surface-protein genes of Borrelia burgdorferi. Mol Biol Evol (1994) 1.67
Isolation of Borrelia burgdorferi from skin biopsy specimens of patients with erythema migrans. Am J Clin Pathol (1993) 1.64
Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease. Infect Immun (1991) 1.63
Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction. J Clin Microbiol (1992) 1.54
Cloning and sequencing of the gene encoding the outer surface protein A (OspA) of a European Borrelia burgdorferi isolate. Nucleic Acids Res (1989) 1.53
Comparison of in vitro culture and polymerase chain reaction for detection of Borrelia burgdorferi in tissue from experimentally infected animals. J Clin Microbiol (1991) 1.43
Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies. Immunobiology (1990) 1.37
Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi. Med Microbiol Immunol (1992) 1.32
Nucleotide sequence of the ospAB operon of a Borrelia burgdorferi strain expressing OspA but not OspB. Infect Immun (1992) 1.29
Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease. J Clin Microbiol (1991) 1.26
Detection of Borrelia burgdorferi DNA by the polymerase chain reaction. Mol Cell Probes (1990) 1.24
Detection of Borrelia burgdorferi by nested polymerase chain reaction in cerebrospinal fluid and urine of children with neuroborreliosis. Eur J Pediatr (1993) 1.22
Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study. Am J Med (1993) 1.12
The polymerase chain reaction for the detection of Borrelia burgdorferi in human body fluids. Arthritis Rheum (1993) 1.11
Polymerase chain reaction amplification of culture supernatants for rapid detection of Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis (1993) 1.06
Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol (1993) 1.04
Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions. J Invest Dermatol (1994) 1.04
Comparison of polymerase chain reaction and culture for detection of Borrelia burgdorferi in naturally infected Peromyscus leucopus and experimentally infected C.B-17 scid/scid mice. J Clin Microbiol (1992) 1.01
Molecular detection of persistent Borrelia burgdorferi in a man with dermatomyositis. Clin Exp Rheumatol (1992) 0.98
Demonstration of Borrelia burgdorferi infection in a child with Guillain-Barré syndrome. Eur J Pediatr (1993) 0.98
Detection of Borrelia burgdorferi in cerebrospinal fluid by the polymerase chain reaction. J Med Microbiol (1991) 0.96
European Lyme borreliosis. Ann N Y Acad Sci (1988) 0.96
Detection of Borrelia burgdorferi in cerebrospinal fluid of patients with Lyme borreliosis. N Engl J Med (1991) 0.96
Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease. J Am Acad Dermatol (1992) 0.95
Detection of Borrelia burgdorferi in biological samples using the polymerase chain reaction assay. Res Microbiol (1991) 0.94
Detection of Borrelia burgdorferi in human blood and urine using the polymerase chain reaction. Pathobiology (1992) 0.93
Diagnostic tests in Lyme borreliosis. Scand J Infect Dis Suppl (1991) 0.85
Molecular diagnosis of Borrelia burgdorferi infection (Lyme disease). DNA Cell Biol (1992) 0.83
Sequence of the complete osp operon encoding two major outer membrane proteins of a European Borrelia burgdorferi isolate (B29) Gene (1992) 0.78
Borrelia burgdorferi isolates from erythema migrans. Arch Dermatol Res (1993) 0.77
Polymerase chain reaction confirmation of Borrelia burgdorferi in benign lymphocytic infiltrate of dermis. J Am Acad Dermatol (1992) 0.77
Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc Natl Acad Sci U S A (1990) 4.15
Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis (1993) 3.92
Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J Infect Dis (1991) 3.58
Specific Lyt 123 cells are involved in protection against Listeria monocytogenes and in delayed-type hypersensitivity to listerial antigens. J Exp Med (1979) 3.31
Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo. Infect Immun (1995) 3.00
The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis. J Exp Med (1989) 2.68
Correlation between structure and pathogenicity of potato spindle tuber viroid (PSTV). EMBO J (1985) 2.63
Persistence of a behavioral food-anticipatory circadian rhythm following dorsomedial hypothalamic ablation in rats. Am J Physiol Regul Integr Comp Physiol (2006) 2.54
Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature (1985) 2.48
Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J Virol Methods (1998) 2.31
Nucleotide sequence of a gene encoding the Borrelia burgdorferi flagellin. Nucleic Acids Res (1989) 2.21
Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am J Pathol (1990) 2.15
Conformational transitions in viroids and virusoids: comparison of results from energy minimization algorithm and from experimental data. J Biomol Struct Dyn (1984) 2.14
No .NO from NO synthase. Proc Natl Acad Sci U S A (1996) 2.14
Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes. Infect Immun (1992) 2.10
The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene. Infect Immun (1990) 2.10
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res (2000) 2.09
Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen. Immunol Lett (1993) 1.84
Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. J Infect Dis (1993) 1.84
Involvement of common and cell type-specific pathways in c-fos gene control: stable induction of cAMP in macrophages. Cell (1987) 1.83
The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor. Proc Natl Acad Sci U S A (1994) 1.76
An avian reservoir (Turdus merula) of the Lyme borreliosis spirochetes. Zentralbl Bakteriol (1998) 1.74
Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis. Eur J Immunol (1991) 1.71
Molecular and immunological characterization of a novel polymorphic lipoprotein of Borrelia burgdorferi. Infect Immun (1993) 1.64
Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor. Lancet (1997) 1.63
Antigenic variation and strain heterogeneity in Borrelia spp. Res Microbiol (1993) 1.60
Localization of flexible sites in thread-like molecules from electron micrographs. Comparison of interstitial, basement membrane and intima collagens. J Mol Biol (1984) 1.59
Monoclonal antibodies against murine cell surface antigens: anti-H-2, anti-Ia and anti-T cell antibodies. Curr Top Microbiol Immunol (1978) 1.55
Cloning and sequencing of the gene encoding the outer surface protein A (OspA) of a European Borrelia burgdorferi isolate. Nucleic Acids Res (1989) 1.53
The dynamic air bubble trap reduces cerebral microembolism during cardiopulmonary bypass. J Thorac Cardiovasc Surg (2003) 1.52
Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J (1995) 1.52
A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease. Immunol Today (1991) 1.52
Molecular and biochemical characterization of a cytokinin oxidase from maize. Plant Physiol (2001) 1.52
Rapid diagnosis of tick-borne encephalitis by means of enzyme linked immunosorbent assay. J Gen Virol (1979) 1.51
Therapeutic passive vaccination against chronic Lyme disease in mice. Proc Natl Acad Sci U S A (1997) 1.50
Interleukin 2 induction in Lyt 1+ 23- T cells from Listeria monocytogenes-immune mice. Infect Immun (1982) 1.49
[Borrelia burgdorferi infection. I. Aspects of basic research, current approach for diagnosis and therapy]. Hautarzt (1990) 1.49
Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc Natl Acad Sci U S A (1999) 1.46
The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection. Eur J Immunol (1987) 1.46
Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses. J Clin Invest (1992) 1.45
Regulatory interactions between macrophages and T-cell subsets in Listeria monocytogenes-specific T-cell activation. Infect Immun (1982) 1.43
Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. Proc Natl Acad Sci U S A (1996) 1.42
Quantitative studies on T cell diversity. I. Determination of the precursor frequencies for two types of streptococcus A-specific helper cells in nonimmune, polyclonally activated splenic T cells. J Exp Med (1980) 1.39
[An increased risk of kinesitherapy in silent myocardial ischemia?]. Dtsch Med Wochenschr (1993) 1.38
Strain variation of Lyme disease spirochetes isolated from Ixodes ricinus ticks and rodents collected in two endemic areas in Switzerland. J Med Entomol (1995) 1.37
The role of polar and hydrophobic interactions for the molecular packing of type I collagen: a three-dimensional evaluation of the amino acid sequence. J Mol Biol (1978) 1.37
Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies. Immunobiology (1990) 1.37
Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. J Clin Oncol (1994) 1.36
Expression of cytoplasmic granules with T cell-associated serine proteinase-1 activity in Ly-2+(CD8+) T lymphocytes responding to lymphocytic choriomeningitis virus in vivo. Eur J Immunol (1989) 1.36
Infestation of rodents with larval Ixodes ricinus (Acari: Ixodidae) is an important factor in the transmission cycle of Borrelia burgdorferi s.l. in German woodlands. J Med Entomol (1995) 1.36
Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol (1997) 1.35
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine (1990) 1.35
Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi. Infect Immun (1992) 1.35
Identification of herpes simplex virus type 1 glycoproteins interacting with the cell surface. J Virol (1990) 1.34
Novel Borrelia burgdorferi isolates from Ixodes scapularis and Ixodes dentatus ticks feeding on humans. J Clin Microbiol (1996) 1.31
Physical activity and gestational weight gain: a meta-analysis of intervention trials. BJOG (2010) 1.29
In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol (1998) 1.28
Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Eur J Immunol (1999) 1.28
Monoclonal antibodies to interferon-gamma inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors. J Immunol (1986) 1.27
Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials (2005) 1.26
Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone. Int Immunol (1994) 1.24
Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae). Infect Immun (1994) 1.24
The superantigen-homologous viral immediate-early gene ie14/vsag in herpesvirus saimiri-transformed human T cells. J Virol (1997) 1.24
Demonstration of antigen-specific T cells and histopathological alterations in mice experimentally inoculated with Borrelia burgdorferi. Infect Immun (1989) 1.24
Epidemiological analysis of Neisseria gonorrhoeae in the Federal Republic of Germany by auxotyping and serological classification using monoclonal antibodies. Genitourin Med (1986) 1.23
The tetratricopeptide repeat-domain of the PAS10 protein of Saccharomyces cerevisiae is essential for binding the peroxisomal targeting signal-SKL. Biochem Biophys Res Commun (1994) 1.23
Effector T lymphocytes in lymphocytic choriomeningitis virus-infected mice. Cytolytic activity of Lyt-23 spleen cells in vitro does not correlate with elimination of infectious virus from spleens. J Exp Med (1981) 1.22